Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
52.79
+0.07 (0.13%)
At close: Apr 1, 2026, 4:00 PM EDT
52.72
-0.07 (-0.13%)
Pre-market: Apr 2, 2026, 8:57 AM EDT
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $6.09 billion as of April 2, 2026. Its market cap has increased by 2,107.08% in one year.
Market Cap
6.09B
Enterprise Value
5.07B
1-Year Change
2,107.08%
Ranking
Category
Stock Price
$52.79
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $6.09B, an increase of 4,142.50%. That is a compound annual growth rate of 107.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 6.08B | 38.47% |
| Dec 31, 2025 | 4.39B | 833.82% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcellx | 6.73B |
| Kymera Therapeutics | 6.71B |
| Protagonist Therapeutics | 6.53B |
| Belite Bio | 6.13B |
| Apogee Therapeutics | 6.09B |
| Cogent Biosciences | 6.03B |
| Centessa Pharmaceuticals | 5.83B |
| Rhythm Pharmaceuticals | 5.71B |